Your browser doesn't support javascript.
loading
Outcomes of patients with severe and critical COVID-19 treated with dexamethasone: a prospective cohort study.
Martinez-Guerra, Bernardo A; Gonzalez-Lara, Maria F; Roman-Montes, Carla M; Tamez-Torres, Karla M; Dardón-Fierro, Francisco E; Rajme-Lopez, Sandra; Medrano-Borromeo, Carla; Martínez-Valenzuela, Alejandra; Ortiz-Brizuela, Edgar; Sifuentes-Osornio, Jose; Ponce-de-Leon, Alfredo.
Afiliação
  • Martinez-Guerra BA; Department of Infectious Diseases, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
  • Gonzalez-Lara MF; Clinical Microbiology Laboratory, Department of Infectious Diseases, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
  • Roman-Montes CM; Department of Infectious Diseases, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
  • Tamez-Torres KM; Clinical Microbiology Laboratory, Department of Infectious Diseases, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
  • Dardón-Fierro FE; Department of Medicine, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
  • Rajme-Lopez S; Department of Infectious Diseases, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
  • Medrano-Borromeo C; Department of Medicine, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
  • Martínez-Valenzuela A; Department of Medicine, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
  • Ortiz-Brizuela E; Department of Infectious Diseases, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
  • Sifuentes-Osornio J; Department of Medicine, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
  • Ponce-de-Leon A; Department of Infectious Diseases, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
Emerg Microbes Infect ; 11(1): 50-59, 2022 Dec.
Article em En | MEDLINE | ID: mdl-34839785
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Dexametasona / SARS-CoV-2 / COVID-19 / Tratamento Farmacológico da COVID-19 Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Emerg Microbes Infect Ano de publicação: 2022 Tipo de documento: Article País de afiliação: México
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Dexametasona / SARS-CoV-2 / COVID-19 / Tratamento Farmacológico da COVID-19 Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Emerg Microbes Infect Ano de publicação: 2022 Tipo de documento: Article País de afiliação: México